These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5562292)

  • 21. Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients.
    Curry SH; Marshall JH
    Life Sci; 1968 Jan; 7(1):9-17. PubMed ID: 5636632
    [No Abstract]   [Full Text] [Related]  

  • 22. High-performance liquid chromatographic assay for nanogram determination of chlorpromazine and its comparison with a radioimmunoassay.
    Midha KK; Cooper JK; McGilveray IJ; Butterfield AG; Hubbard JW
    J Pharm Sci; 1981 Sep; 70(9):1043-6. PubMed ID: 6101152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of mode of management on plasma chlorpromazine in psychiatric patients.
    Rivera-Calimlim L; Castañeda L; Lasagna L
    Clin Pharmacol Ther; 1973; 14(6):978-86. PubMed ID: 4584156
    [No Abstract]   [Full Text] [Related]  

  • 24. Disappearance of chlorpromazine from plasma following drug withdrawal.
    Phillipson O; Baker J; Sebastianpillai F; Sheppard G; Brook P
    Psychol Med; 1978 May; 8(2):331-4. PubMed ID: 418432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of chlorpromazine and its metabolites by two-dimensional thin-layer chromatography and direct scanning microdensitometry.
    Turano P; Turner WJ
    J Chromatogr; 1972 Feb; 64(2):347-54. PubMed ID: 5013113
    [No Abstract]   [Full Text] [Related]  

  • 26. Chromatographic properties of imines formed from dedimethylchlorpromazine and various aldehydes and ketones.
    Whelpton R; Curry SH
    J Chromatogr; 1976 Jun; 121(1):88-92. PubMed ID: 932139
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors affecting chlorpromazine plasma levels in psychiatric patients.
    Curry SH; Davis JM; Janowsky DS; Marshall JH
    Arch Gen Psychiatry; 1970 Mar; 22(3):209-15. PubMed ID: 5413268
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug plasma levels and clinical effect.
    Crammer JL
    Proc R Soc Med; 1971 Mar; 64(3):289-90. PubMed ID: 5551486
    [No Abstract]   [Full Text] [Related]  

  • 29. Test dose response in schizophrenia: chlorpromazine blood and saliva levels.
    May PR; Van Putten T; Jenden DJ; Cho AK
    Arch Gen Psychiatry; 1978 Sep; 35(9):1091-7. PubMed ID: 686971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis.
    Maxwell JD; Carrella M; Parkes JD; Williams R; Mould GP; Curry SH
    Clin Sci; 1972 Aug; 43(2):143-51. PubMed ID: 5048301
    [No Abstract]   [Full Text] [Related]  

  • 31. Chlorpromazine analysis by gas chromatography with an electron-capture detector.
    Curry SH
    Adv Biochem Psychopharmacol; 1974; 9(0):335-45. PubMed ID: 4836210
    [No Abstract]   [Full Text] [Related]  

  • 32. Physiologic and clinical effects of chlorpromazine and their relationship to plasma level.
    Sakalis G; Curry SH; Mould GP; Lader MH
    Clin Pharmacol Ther; 1972; 13(6):931-46. PubMed ID: 5081606
    [No Abstract]   [Full Text] [Related]  

  • 33. Mass fragmentography. Identification of chlorpromazine and its metabolites in human blood by a new method.
    Hammar CG; Holmstedt B; Ryhage R
    Anal Biochem; 1968 Oct; 25(1):532-48. PubMed ID: 5704768
    [No Abstract]   [Full Text] [Related]  

  • 34. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M; Palmi M; Della Corte L; Nardini M; Corti P; Sgaragli GP
    Methods Find Exp Clin Pharmacol; 1992; 14(6):445-50. PubMed ID: 1469953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic monitoring of chlorpromazine. IV: Comparison of a new high-performance liquid chromatographic method with radioimmunoassays for parent drug and some of its major metabolites.
    Midha KK; Hubbard JW; Cooper JK; Gurnsey T; Hawes EM; McKay G; Chakraborty BS; Yeung PK
    Ther Drug Monit; 1987 Sep; 9(3):358-65. PubMed ID: 3672582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid-phase extraction and high-performance liquid chromatographic method for chlorpromazine and thirteen metabolites.
    Smith CS; Morgan SL; Greene SV; Abramson RK
    J Chromatogr; 1987 Dec; 423():207-16. PubMed ID: 3443651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative determination of chlorpromazine and thioridazine by high-performance thin layer chromatography.
    Davis CM; Harrington CA
    J Chromatogr Sci; 1984 Feb; 22(2):71-4. PubMed ID: 6699120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous determination of chlorpromazine and levomepromazine in human plasma and urine by high-performance liquid chromatography using electrochemical detection.
    Murakami K; Murakami K; Ueno T; Hijikata J; Shirasawa K; Muto T
    J Chromatogr; 1982 Jan; 227(1):103-12. PubMed ID: 7056803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of chlorpromazine metabolites--a colossal problem.
    Kaul PN; Conway MW; Clark ML
    Adv Biochem Psychopharmacol; 1974; 9(0):391-8. PubMed ID: 4836215
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic monitoring of chlorpromazine. III: Minimal interconversion between chlorpromazine and metabolites in human blood.
    Hawes EM; Hubbard JW; Martin M; McKay G; Yeung PK; Midha KK
    Ther Drug Monit; 1986; 8(1):37-41. PubMed ID: 3961895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.